scPharmaceuticals Inc. SCPH
5.67 0.00 (+0.00%)
At closeOct 7, 2025, 4:00 PM EDT
5.67 Day range 5.67
52-week range unavailable
- YTD
- +60.17%
- 1 year
- +32.48%
News
businesswire.com SCPHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of scPharmaceuticals Inc. - SCPH NEW YORK CITY & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of…
globenewswire.com SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates VTLE and SCPH on Behalf of Shareholders NEW YORK, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or…
globenewswire.com SCPH Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Sale of scPharmaceuticals to MannKind MONSEY, N.Y., Aug. 25, 2025 (GLOBE NEWSWIRE) -- The law firm of Wohl & Fruchter LLP is investigating the fairness of the sale of scPharmaceuticals, Inc. (Nasdaq: SCPH) (“SCPH”) to MannKind…
benzinga.com MannKind, Backed By Blackstone, Expands Cardiorenal Focus With $360 Million Deal MannKind will acquire scPharmaceuticals in a $360 million deal, adding Furoscix and expanding into cardiometabolic care with a $10 billion U.S. market opportunity.
businesswire.com SCPH Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of scPharmaceuticals Inc. Is Fair to Shareholders NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of scPharmaceuticals Inc. (NASDAQ: SCPH) to MannKind Corporation is fair to…
businesswire.com Shareholder Alert: The Ademi Firm Investigates Whether scPharmaceuticals Inc. Is Obtaining a Fair Price for Its Public Shareholders MILWAUKEE--(BUSINESS WIRE)--The Ademi Firm is investigating scPharmaceuticals (NASDAQ: SCPH) for possible breaches of fiduciary duty and other violations of law in its transaction with MannKind.…
benzinga.com 12 Health Care Stocks Moving In Monday's Pre-Market Session 
globenewswire.com MannKind to Acquire scPharmaceuticals, Accelerating Revenue Growth and Emerging as a Patient-Centric Leader in Cardiometabolic and Lung Diseases DANBURY, Conn. and BURLINGTON, Mass., Aug. 25, 2025 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD) and scPharmaceuticals Inc. (Nasdaq: SCPH) today announced the signing of a definitive…
globenewswire.com scPharmaceuticals Receives Notice of Allowances of Multiple US Patent Applications Covering SCP-111 BURLINGTON, Mass., Aug. 14, 2025 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH) (the “Company”), a pharmaceutical company committed to revolutionizing cardiorenal healthcare through…
seekingalpha.com scPharmaceuticals Inc. (SCPH) Q2 2025 Earnings Call Transcript scPharmaceuticals Inc. (NASDAQ:SCPH ) Q2 2025 Earnings Conference Call August 7, 2025 4:30 PM ET Company Participants John Mohr - Senior Vice President of Clinical Development & Medical Affairs John…
zacks.com scPharmaceuticals, Inc. (SCPH) Reports Q2 Loss, Lags Revenue Estimates scPharmaceuticals, Inc. (SCPH) came out with a quarterly loss of $0.34 per share versus the Zacks Consensus Estimate of a loss of $0.3. This compares to a loss of $0.44 per share a year ago.
globenewswire.com scPharmaceuticals Inc. Reports Second Quarter 2025 Financial Results and Provides Business Update Generated net FUROSCIX ® revenue of $16 million in the second quarter of 2025; up 99% over Q2 2024
benzinga.com Earnings Scheduled For August 7, 2025 
globenewswire.com scPharmaceuticals to Announce Second Quarter 2025 Financial Results After the Market Close on August 7, 2025 BURLINGTON, Mass., July 31, 2025 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company committed to revolutionizing cardiorenal healthcare through patient-centric…
zacks.com scPharmaceuticals (SCPH) Soars 8.8%: Is Further Upside Left in the Stock? scPharmaceuticals (SCPH) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength…
seekingalpha.com scPharmaceuticals: Furoscix Sales To Accelerate Throughout 2025 Shares of scPharmaceuticals have lost 37% over the past 3 years and are down 11% in 2025. Furoscix's subcutaneous administration offers the potential to keep heart failure patients at home longer and…
seekingalpha.com scPharmaceuticals Inc. (SCPH) Q1 2025 Earnings Call Transcript scPharmaceuticals Inc. (NASDAQ:SCPH ) Q1 2025 Earnings Conference Call May 14, 2025 4:30 PM ET Company Participants William Thorpe - Investor Relations John Tucker - Chief Executive Officer Steve…
zacks.com ScPharmaceuticals, Inc. (SCPH) Reports Q1 Loss, Misses Revenue Estimates ScPharmaceuticals, Inc. (SCPH) came out with a quarterly loss of $0.34 per share versus the Zacks Consensus Estimate of a loss of $0.27. This compares to loss of $0.36 per share a year ago.
globenewswire.com scPharmaceuticals Inc. Reports First Quarter 2025 Financial Results and Provides Business Update Generated net FUROSCIX ® revenue of $11.8 million in the first quarter of 2025 Formally launched FUROSCIX in second approved indication, Chronic Kidney Disease, in April 2025 Autoinjector on track…
benzinga.com Earnings Scheduled For May 14, 2025 
globenewswire.com scPharmaceuticals to Announce First Quarter 2025 Financial Results After the Market Close on May 14, 2025 Management to host conference call and webcast, after-market on May 14, 2025, at 4:30 p.m. ET Management to host conference call and webcast, after-market on May 14, 2025, at 4:30 p.m. ET
globenewswire.com scPharmaceuticals Announces Participation in Three Upcoming Investor Conferences BURLINGTON, Mass., May 01, 2025 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH) (the “Company”), a pharmaceutical company committed to revolutionizing cardiorenal healthcare through…
seekingalpha.com scPharmaceuticals Inc. (SCPH) Q4 2024 Earnings Call Transcript scPharmaceuticals Inc. (NASDAQ:SCPH ) Q4 2024 Results Conference Call March 19, 2025 4:30 PM ET Company Participants Nick Colangelo - Investor Relations John Tucker - Chief Executive Officer Steve…- benzinga.com Earnings Scheduled For March 19, 2025
benzinga.com Earnings Scheduled For November 13, 2024 - benzinga.com Earnings Scheduled For March 13, 2024 Companies Reporting Before The Bell • Sangamo Therapeutics (NASDAQ:SGMO) is likely to report quarterly loss at $0.26 per share on revenue of $8.10 million.
- benzinga.com 12 Health Care Stocks Moving In Monday's Pre-Market Session
benzinga.com Earnings Scheduled For November 8, 2023 Companies Reporting Before The Bell • Flex LNG (NYSE:FLNG) is estimated to report earnings for its third quarter.- benzinga.com Benzinga's Top Ratings Upgrades, Downgrades For September 7, 2023
benzinga.com Earnings Scheduled For August 10, 2023 Companies Reporting Before The Bell • IDEX Biometrics (NASDAQ:IDBA) is estimated to report quarterly loss at $0.39 per share on revenue of $1.60 million.- benzinga.com Earnings Scheduled For May 10, 2023 Companies Reporting Before The Bell • Nomad Foods (NYSE:NOMD) is projected to report quarterly earnings at $0.42 per share on revenue of $851.81 million.
benzinga.com Why Block Shares Are Trading Lower By Over 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session Gainers DiamondHead Holdings Corp. (NASDAQ: DHHC) shares jumped 104.2% to $21.15. DiamondHead entered into convertible note purchase agreement dated March 21, 2023.
benzinga.com KB Home, Accenture, Netflix And Other Big Stocks Moving Higher On Thursday U.S. stocks traded higher, with the Dow Jones gaining around 200 points on Thursday. Here are some big stocks recording gains in today’s session.- benzinga.com Earnings Scheduled For March 22, 2023 Companies Reporting Before The Bell • Boyd Gaming (NYSE:BYD) is estimated to report quarterly earnings at $1.09 per share on revenue of $848.27 million.
- benzinga.com Earnings Scheduled For November 9, 2022 Companies Reporting Before The Bell • GCM Grosvenor (NASDAQ:GCMG) is likely to report quarterly earnings at $0.11 per share on revenue of $103.46 million.
benzinga.com Why Laser Photonics Shares Jumped By Around 44%; Here Are 72 Biggest Movers From Yesterday Gainers FedNat Holding Company (NASDAQ: FNHC) shares climbed 107.7% to close at $0.3395 on Tuesday.- benzinga.com Dow Rises 30 Points; Crude Oil Down 2% U.S. stocks traded mixed toward the end of trading, with the Dow Jones gaining around 30 points on Monday.
- benzinga.com Nasdaq Dips 150 Points; Gold Down 2% U.S. stocks pared gains midway through trading, with the Dow Jones dropping more than 100 points on Monday.
- benzinga.com Why Myovant Sciences Is Trading Higher By Over 26%; Here Are 31 Stocks Moving Premarket Gainers Wearable Devices Ltd. (NASDAQ: WLDS) rose 58% to $1.39 in pre-market trading after declining around 8% on Friday. Wearable Devices, last week, posted a 1H loss of $0.18 per share.
- benzinga.com Benzinga's Top Ratings Upgrades, Downgrades For September 9, 2021
benzinga.com 78 Biggest Movers From Yesterday Gainers Obalon Therapeutics, Inc. (NASDAQ: OBLN) shares climbed 115% to close at $2.30 on Monday after declining around 5% on Friday.- benzinga.com 54 Stocks Moving In Monday's Mid-Day Session Gainers Obalon Therapeutics, Inc. (NASDAQ: OBLN) shares jumped 115.9% to $2.31 after declining around 5% on Friday.
- benzinga.com 28 Stocks Moving in Thursday's Pre-Market Session Gainers Aurora Cannabis Inc. (NYSE: ACB) shares rose 34.1% to $17.10 in pre-market trading after the company announced plans to acquire CBD platform Reliva for $40 million in Aurora common shares.
- benzinga.com 108 Biggest Movers From Yesterday
- benzinga.com Stocks That Hit 52-Week Highs On Friday
- benzinga.com 95 Biggest Movers From Yesterday
- benzinga.com Stocks That Hit 52-Week Highs On Thursday
- benzinga.com Stocks That Hit 52-Week Highs On Tuesday
- benzinga.com 52 Biggest Movers From Yesterday
- benzinga.com Stocks That Hit 52-Week Highs On Monday